The Ebola virus saga in Nigeria; the view point of a microbiologist

Authors

  • Lillian Yami Adogo, Department of Biological Sciences, Faculty of Science and Technology, Bingham University, Karu, Nasarawa State, Nigeria.
  • Aleruchi Chuku Department of Microbiology, Faculty of Science, Federal University, Lafia, Nasarawa State, Nigeria.
  • Bukola Ajide Department of Biological Sciences, Faculty of Science and Technology, Bingham University, Karu, Nasarawa State, Nigeria.

DOI:

https://doi.org/10.30574/gscbps.2019.9.2.0188

Keywords:

Ebola virus disease, Haemorrhagic fever, Transmission, Nigeria

Abstract

The largest Ebola Virus Disease outbreak in history exploded across West Africa. The World Health Organization  reported a total of 21,296 Ebola virus disease (EVD) cases, including 13,427 laboratory confirmed EVD cases reported from the three most affected countries Guinea, Liberia, and Sierra Leone in 2014. Nigeria’s first case of EVD was officially announced in July, 2014. In an effort to tackle the Ebola outbreak in Nigeria, the Federal Government, drawing on the experience of the Emergency Operation Centre’s work with polio, declared Ebola a public health emergency and mobilized human, financial and material resources to contain the epidemic. Nigeria was officially declared Ebola free on 20th October 2014. However, the current Ebola outbreak in the Democratic Republic of Congo (DRC) has spread internationally from the DRC into neighbouring Uganda and it ranks as the second deadliest outbreak in history. This ongoing epidemic hereby calls for intensified disease monitoring at the Nigerian border posts, health centers and communities, and a prompt review of preparedness activities in the country to prevent another outbreak.

Metrics

Metrics Loading ...

References

WHO. (2005).International Public Health Threats in the 21st Century. International Health Regulations Areas of work for implementation.

Feldmann H. (2014). Ebola; A Growing Threat? N. Engl. J. Med, 371, 1375–1378.

World Health Organization. (2012). Ebola Hemorrhagic Fever. Epidemic and Pandemic Alert and Response.

World Health Organization. (2017). Ebola virus disease update, West Africa – update 28 August 2014: Epidemic & Pandemic Alert and Response (EPR) – Outbreak News.

Borio L, Inglesby T, Peters CJ and Schmaljohn, AL. (2002). Hemorrhagic fever viruses as biological weapons: medical and public health management. Journal of the American Medical Association, 287, 2391-2405.

Centers for Disease Control and Prevention. (2002). Special Pathogens Branch CDC 2002."Known Cases and Outbreaks of Ebola Hemorrhagic Fever".

McElroy AK, Erickson BR, Flietstra TD and Rollin PE. (2014). Ebola hemorrhagic fever: novel biomarker correlates of clinical outcome. J Infect Dis, 210 (4), 558-566.

World Health Organization Ebola Virus Disease. (2017).Democratic Republic of the Congo. External Situation Report 23.Health Emergency Information and Risk Assessment. 1-6.

World Health Organization. (2018). Cluster of presumptive Ebola cases in North Kivu in the Democratic Republic of the Congo".

World Health Organization. (2019). Ebola virus disease – Democratic Republic of the Congo. Disease outbreak news: Update.

World Health Organization. (2019). Ebola virus disease –Republic of Uganda. Disease outbreak news: Update.

Shuaib F, Gunnala R, Musa EO and Mahoney FJ. (2014). Ebola virus disease outbreak – Nigeria, July‑September 2014. MMWR Morb Mortal Weekly Rep, 63, 867‑72.

Althaus CL, Low N, Musa EO and Shuaib F. (2015). Ebola virus disease outbreak in Nigeria: Transmission dynamics and rapid control. Peer J Pre Prints, 3, e569v3.

Bureau of Public Service Reforms. (2015). How Nigeria Contained Ebola: Lessons For Institutional Reform 2015. Bureau of Public Service Reforms, Abuja, Nigeria.

Oleribe OO, Crossey MM and Taylor-Robinson SD. (2015). Nigerian response to the 2014 Ebola viral disease outbreak: Lessons and cautions. Pan Afr Med J, 22 Suppl 1, 13.

Centers for Disease Control and Prevention. (2014).Treatment of Ebola Hemorrhagic Fever.

Baize S, Pannetier D and Oestereich L. (2014). Emergence of Zaire Ebola virus disease in Guinea. N Engl J Med, 371, 1418–25.

Shittu RO, Sanni MA, Odeigah LO and Akanbi AA. (2015). Awareness Knowledge and Misconceptions about Ebola Virus Disease (EVD) in a Family Practice Setting in Nigeria. West Africa J, 7, 010-014.

Feldmann H and Geisbert T. (2011). Ebola haemorrhagic fever. Lancet, 377 (9768), 849-862.

Stein RA. (2015).What is Ebola? Int J ClinPract, 69 (1), 49-58.

Olson SH, Reed P, Cameron KN and Ssebide BJ. (2012).Dead or alive: animal sampling during Ebola hemorrhagic fever outbreaks in humans. Emerg Health Threats J, 10.3402/ehtj.v5i0.9134.

Chippaux JP. (2014). Outbreaks of Ebola virus disease in Africa: the beginnings of a tragic saga. J Venom Anim Toxins Incl Trop Dis, (20), 44.

World Health Organization. (2014). Ebola virus disease update, West Africa – update 28 August 2014, Epidemic & Pandemic Alert and Response (EPR) Outbreak News.

Ansari AA. (2014). Clinical features and pathobiology of Ebola virus infection. J Autoimmun, 55. 1-9.

World Health Organization. (2019). Ebola virus disease. Key Facts. (www.who.int) Assessed on 19th June 2019.

Jean-Philippe C. (2014). Outbreaks of Ebola virus disease in Africa: the beginnings of a tragic saga. Journal of Venomous Animals and Toxins including Tropical Diseases, 20, 44.

Huttner A, Dayer JA and Yerly S. (2015). The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomized double-blind, placebo-controlled phase 1/2 trial. Lancet Infect Dis, 15, 1156–1166.

Henao-Restrepo AM, Camacho A and Longini IM. (2016). Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease expressing Ebola virus surface glycoprotein: final results from the Guinea ring vaccination, open-label, cluster-randomized trial. Lancet, 389, 05-518.

www.premiumtimesng.com/health/health-news/335412-nigeria-not-at-risk-of-ebola-outbreak-ncdc.html [Accessed June19, 2019].

www.saharareporters.com/2019/06/17/possibility-outbreak-ebola-nigeria-very-low-says-nigeria-centre-disease-control [Accessed June19, 2019].

www.reliefweb.int/report/nigeria/evd-ncdc-conducts-risk-assessment-amidst-ongoing-outbreak-drc-and Uganda [Accessed June19, 2019].

Downloads

Published

2019-11-30

How to Cite

Adogo, L. Y., Chuku, A., & Ajide, B. (2019). The Ebola virus saga in Nigeria; the view point of a microbiologist. GSC Biological and Pharmaceutical Sciences, 9(2), 050–056. https://doi.org/10.30574/gscbps.2019.9.2.0188

Issue

Section

Review Article